#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypocalcaemia Oropharyngeal squamous cell carcinoma Fibrosarcoma B-cell lymphoma refractory Hormone-dependent prostate cancer Heavy menstrual bleeding Medulloblastoma Cryoglobulinaemia Infantile apnoea Gaucher's disease type I Small cell lung cancer Activated PI3 kinase delta syndrome Arterial tortuosity syndrome Thrombocytopenia Primary mediastinal large B-cell lymphoma More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranoproliferative Leukoencephalopathy – Life with Disease Mucopolysaccharidosis I – Basic Information Idiopathic pulmonary fibrosis – Life with Disease Combined immunodeficiency – Life with Disease Behcet’s syndrome – Basic Information Rhabdomyosarcoma Noonan syndrome – Life with Disease Pulmonary fibrosis – Treatment Nephrotic syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mk-6194 Naloxone Hydrochloride Levoleucovorin Disodium Silibinin Human Coagulation Factor Viii Capsaicin Phleum Pratense (225) Isatuximab Methylprednisolone Acetate TUVATEXIB Apitegromab Fludarabine Phosphate Ph. Eur. Meglumine Gadoterate SARACATINIB Risdiplam Ttf-Ngr Soya-Bean Oil Refined Rocatinlimab Letetresgene Autoleucel Pantoprazole More therapies…

    Learn about Your Condition

    Epileptic encephalopathy Intestinal obstruction Glucose tolerance impaired Dermatitis Chronic granulomatous disease Arterial stiffness Biliary adenoma Urinary incontinence Chondropathy Chordoma Hepatoblastoma Cold type haemolytic anaemia Femoral neck fracture End stage renal disease Type IIa hyperlipidaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Cenegermin Nasal Spray for Safety and Tolerability in Children with Spastic Cerebral Palsy

    Recruiting

    2 1
    Investigated Drugs:
    • Cenegermin
    Italy

  • A Study Testing How Well Faricimab Works in Patients with Subretinal Hyperreflective Material Associated with Neovascular Membranes in the Eye

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Eye disorder
    Investigated Drugs:
    • Faricimab
    Spain

  • A study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis

    Recruiting

    2 1
    Investigated Drugs:
    • XMAB942
    Bulgaria Croatia France Germany Greece Hungary +5

  • Study of GS-4321 for Healthy People and Patients With Chronic Hepatitis Delta Virus Infection

    Recruiting

    2 1
    Investigated Drugs:
    • GS-4321
    Bulgaria Germany Italy Romania

  • Study of TranspoCART19 cell therapy for patients with CD19-positive acute lymphoblastic leukemia that is resistant or refractory to treatment

    Recruiting

    1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Transpocart19
    Spain

  • A study comparing prasinezumab with placebo for people with early-stage Parkinson’s disease

    Recruiting

    3 1
    Investigated Drugs:
    • Prasinezumab
    Austria Denmark France Germany Italy The Netherlands +3
Previous Page
1 … 70 71 72 73 74 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!